Private company
Collaborative Drug Discovery
Logo: Jharri43, CC BY-SA 4.0, via Wikimedia Commons3
Collaborative Drug Discovery (CDD) is a software company founded in 2004 as a spin-out of Eli Lilly by Barry Bunin, PhD. CDD utilizes a web-based database solution for managing drug discovery data, primarily through the CDD Vault product which is focused around small molecules and associated bio-assay data. In 2021, CDD launched its first commercial data offering, PharmaKB, formerly BioHarmony, as The Pharma KnowledgeBase, which is centered around pharma company, drug, and disease information for research, business intelligence, and investors.2 It is headquartered in Burlingame.1 Wikipedia text CC BY-SA 4.0
Last updated Oct 21, 2026.
Overview
- Industryinformation technology1
- HeadquartersBurlingame1
- Websitewww.collaborativedrug.com
See how the biggest companies compare on our leaderboards
Collaborative Drug Discovery (CDD) is a software company founded in 2004 as a spin-out of Eli Lilly by Barry Bunin, PhD. CDD utilizes a web-based database solution for managing drug discovery data, primarily through the CDD Vault product which is focused around small molecules and associated bio-assay data. In 2021, CDD launched its first commercial data offering, PharmaKB, formerly BioHarmony, as The Pharma KnowledgeBase, which is centered around pharma company, drug, and disease information for research, business intelligence, and investors.2
Products and brands
1. CDD Vault is a research informatics web platform by Collaborative Drug Discovery. It contains several modules for collaborative project teams to manage, analyze, and share both private & public data. It is used by biotech companies, CROs, academic labs, research hospitals, agrochemical and consumer goods companies. CDD Vault is a modern web application for chemical registration, assay data management, and SAR analysis. It is designed to be simple to use and extremely secure.
2. PharmaKB is a knowledgebase for pharma-related information. Available data spans (preclinical, clinical, financial, patents, and post-approval) information about companies, drugs, and diseases. It is designed to be used by researchers, those practicing business intelligence, and investors. PharmaKB also offers real-time updates with a subscription model instead of static reports. As a throwback to CDD Vault's slogan of "Complexity Simplified", PharmaKB uses the slogan of "Data Simplified" and promotes a data trilogy of Company, Drug, and Disease. The product is meant to expand the company's scope from working with mostly preclinical researchers to being relevant for clinical and post-approval stages of drug development, including: Pharmacovigilance or Drug Safety, Regulatory Affairs, Competitive Intelligence - also referred to as Pharma Intelligence within its industry, and Pharmacoeconomics as well as investors and publishers of medical content.
From Wikipedia’s article on Collaborative Drug Discovery, shared under CC BY-SA 4.0.4
Timeline
- 2004Founded Founded1
Funding
Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.
- PPP loans $437.4K
Figures by year
| Year | PPP loans | Total |
|---|---|---|
| 2020 | $437.4K | $437.4K |
PPP loans
Paycheck Protection Program loans of $150,000 and up, approved April 2020 to July 2021, from the SBA5. Matched to this company by name and state.
- Apr 30, 2020$437.4K PPP loan (first draw) from Northeast Bank5To COLLABORATIVE DRUG DISCOVERY, INC., Burlingame CA; $440.1K forgiven Dec 17, 2020
Links
- Websitewww.collaborativedrug.com1
- WikipediaCollaborative Drug Discovery
- WikidataQ5145817
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3Wikimedia CommonsCollaborative Drug Discovery logo by Jharri43, CC BY-SA 4.0
- 4
- 5